PHARMA THIRD PARTY CONTRACT MANUFACTURER OF CEFUROXIME AXETIL & POTASSIUM CLAVULANATE
Cefuroxime is a semi-synthetic beta-lactamase resistant, second- Generation Cephalosporin antibiotic & is used as a proproduct which after metabolizing converted into its active form which is Cefuroxime. Clavulanic acid/potassium clavulanate is beta-lactamase inhibitor which is used to enhance the anti bactericidal activity of Cefuroxime.
Antibacterial-Spectrum of this product is a broad-spectrum product & active against gram-positive- streptococcus & Gram negative- E.Coli.
Mechanism of action
As Cefuroxime has bactericidal action (kill/destruction of bacteria) it will inhibit the synthesis of the cell wall of bacteria thereby stop the growth of bacteria as a result of which infection-causing bacteria will die. Potassium clavulanate/clavulanic acid is itself a beta-lactamase inhibitor although it has less antimicrobial activity but is added in this combination to prevent the destruction of Cefuroxime.
The serum half-life of cefuroxime is -1.2 hours.
Protein binding is 50% & is rapidly hydrolyzed
Pharmacological uses Cefuroxime & potassium clavulanate can be prescribed in infection caused by bacteria, the indications are Respiratory tract infections, Otitis media, Pharyngitis, Sinusitis, Bronchitis, Urinary Tract Infections (UTI), and Lyme disease & Impetigo.
Side effects of Cefuroxime & Potassium clavulanate
The adverse effect of this combination is-
Accumulation of gas
Dizziness & drowsiness
Probenecid decreases renal clearance of Cefuroxime.
Nephrotoxicity with Aminoglycosides & Furosemide.
Dosage- Oral tablet & suspension is available in this product. 500 mg of Cefuroxime & 125 mg of Clavulanic acid.
We are the supplier of CEFUROXIME & POTASSIUM CLAVULANATE & also a trader of CEFUROXIME & POTASSIUM CLAVULANATE.
* The following symptoms are suggestive & needs to be confirmed before promoting or coating anywhere & anybody whom so ever. Power2pharma.com & its parent company NEWS pharma Pvt. Ltd. is not responsible for its authenticity.